Market News AIOpen the app

SCTX stock news · Scribe Therapeutics

Stories about Scribe Therapeutics (SCTX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for SCTX

Follow Scribe Therapeutics (SCTX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for SCTX
Free on the App Store and Google Play, or on the web.
  1. Nov 9, 2026, 5:37 PM ET · Market

    ARK Invest bought 37,246 more shares of Scribe Therapeutics to boost its investment in gene therapy.

    Neutral

    ARK Invest bought about 37,000 Scribe Therapeutics shares. The report describes a portfolio shift, not a change in Scribe's business, so its outlook is unchanged.

  2. Sep 30, 2026, 1:17 PM ET · Market

    12 health care companies are seeing big changes in their stock prices today.

    Neutral

    Scribe Therapeutics shares fell 21% to $18.17. The article gives no company news explaining the move, so it does not change the business outlook.